The PROMISE Study: Duavee in Women With DCIS
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Ductal Breast Carcinoma In Situ|Postmenopausal
Interventions: DRUG: Conjugated Estrogens/Bazedoxifene|OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacological Study|OTHER: Placebo|PROCEDURE: Quality-of-Life Assessment|OTHER: Questionnaire Administration
Sponsor: Northwestern University
Collaborators: National Cancer Institute (NCI)|Pfizer|University of Chicago - Department for Cancer Research|University of California, San Francisco